Análise da imunoexpressão da esclerostina em lesões fibro-ósseas dos maxilares
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Sclerostin, a product of the SOST gene, acts as a negative regulator of bone
formation, primarily because of its properties of inhibition of some signaling pathways
related to bone remodeling. The sclerostin is mainly secreted by osteocytes, but also,
by other cell populations. The aim of the study was to assess the sclerostin
expression in Benign Fibro‑Osseous Lesions (BFOL) of the jaws. A retrospective,
transversal, unicenter study selected the cases diagnosed as BFOL. The selected
cases were retrieved, and the paraffin blocks were assessed for histological slides to
be submitted for a) histochemistry by Hematoxylin and Eosin stain; b)
immunohistochemistry for sclerostin expression. For the control group, 6 cases of
normal bone harvested from healthy individuals were selected. A total of 66
histological slides from 40 biopsies of 32 patients were analyzed, 20 lesions in
females (62.5%) and 12 lesions (37.5%) in male individuals. Eighteen cases were
classified as BFOL based only on the anatomical analysis, and the other cases were
classified by both clinical and pathological diagnosis, as follows: 06 cases of Fibrous
Dysplasia; 4 cases of Juvenile trabecular ossifying fibroma; 2 cases of
Psammomatoid ossifying fibroma; and 2 cases of Cemento-osseous dysplasia. There
was a positive sclerostin expression in 21 biopsies (52.5%). The marked cells were
more present in the fibrous tissue than in the bone. In the cases with positivity in the
osteocytes, only 2 were revealed to be in the intralesional bone, and in the other
cases, the positivity was found to be in the osteocytes within the perilesional bone. At
the fibrous component, marked cells revealed a phenotype similar to the mast cells,
and the sclerostin-positive cells were majorly close to the vascular spaces. In the
control group, it was found that sclerostin was expressed in cells both at the
medullary spaces and in a few osteocytes. In conclusion, Benign Fibro‑Osseous
Lesions can express sclerostin, and this expression is mostly concentrated in the
fibrous tissue, in mast cell-like cells. In addition, sclerostin is also expressed in the
intralesional bone in some specific cases, and on the lesion-surrounding bone.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

